Reveal Biosciences is creating a new generation of data powered pathology to enhance research and improve global healthcare.
Cancer has impacted the lives of many of our friends and family. Reveal was founded in 2012 by Claire Weston and Casey Laris with a vision towards pathology driven by data. Our team is creating artificial intelligence technologies for whole slide pathology images that increase accuracy, reproducibility and scale. If the technology we’re building today had been available 15 years ago, a cancer misdiagnosis in Casey’s own family would likely have been caught. We see that by taking a quantitative approach, the data generated by our tools benefits preclinical research, clinical trials, and ultimately patients.
We are proud to partner with the following organizations
Latest research, in the news, or at events.
This is Part Two in a series. In Part One, learn how Reveal’s digital assay pipeline addresses common logistical and technical challenges associated with digital image analysis . What
Analyzing whole slide pathology images at scale is challenging due to the large size of the data and the complexity of models required to quantify a broad range of
What is in situ hybridization? In situ hybridization (ISH) is a method which allows the localization of specific DNA or RNA sequences within a section of tissue using a